Sun Pharmaceutical Industries

Activities: Research & Development Pharmaceutical

Trending Articles

  1. ICROM has acquired HOLODIAG ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
  2. Blood plasma processing: when every drop counts Plasma derivatives obtained from human blood support the treatment of various diseases — from haemophilia and antigen defects to COVID-19. The products are in high demand and...
  3. Rentschler Biopharma boosts UK end-to-end lentiviral vector manufacturing capabilities The company can now develop and produce LVVs for the biopharmaceutical market, which have a high potential in treating a range of diseases
  4. IC Biomedical confirms Biopharma Group as its cryogenic storage vessel service provider IC Biomedical has designated Biopharma Group as its Premier Service Provider for the full range of cryogenic storage vessels across the UK and Ireland
  5. What’s the difference between a factory acceptance test and site acceptance testing? When manufacturing complex machinery in industries such as pharmaceuticals or fine chemicals, extensive equipment testing must be carried out before commissioning

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Drug Delivery

Sun Pharma enters definitive financial agreement with Concert

Concert stockholders will also receive a tradable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share of common stock in cash
Ingredients

Sun Pharma questions pandemic effects on business

Director has said performance reflects the impact of the global COVID-19 pandemic but vertical integration has benefitted supply chain for formulations
Finance

Sun Pharma licenses seven generics to Chinese company

China Medical System Holdings subsidiary will develop and commercialise the Indian company's seven generic products for Mainland China
Finance

Sun Pharma to operate manufacturing plants in Japan

India's drugmaker taps into dermatology market with acquisition of Japan-based Pola Pharma
Pharmaceutical

Sun Pharma opens new cGMP production line in India

The Mumbai-based company has installed a production line in Guwahati to enhance the manufacturing capacity of sterile products

Regulatory filing of tildrakizumab in Europe

Potential of tildrakizumab for patients with moderate-to-severe plaque psoriasis, without burden of frequent injections
Finance

Almirall pays Sun Pharma $50 million upfront in licensing deal for psoriasis treatment in Europe

Phase III clinical trials of tildrakizumab were completed in May, with positive results
Subscribe now